Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-25 Sale |
2025-03-26 4:30 pm |
Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Scientific Officer |
2,631 | $6.6 | $17,365 | 221,373 (Direct) |
View |
| 2025-03-21 Sale |
2025-03-25 4:30 pm |
Trevi Therapeutics Inc. | TRVI | GOOD JENNIFER L President & CEO |
5,263 | $6.5789 | $34,625 | 213,313 (Direct) |
View |
| 2025-03-10 Sale |
2025-03-12 4:00 pm |
Trevi Therapeutics Inc. | TRVI | Simon Farrell Chief Commercial Officer |
81,313 | $6.7502 | $548,878 | 145,237 (Direct) |
View |
| 2024-09-06 Sale |
2024-09-09 5:00 pm |
Trevi Therapeutics Inc. | TRVI | GOOD JENNIFER L President & CEO |
6,059 | $3.032 | $18,371 | 215,153 (Direct) |
View |
| 2024-09-03 Sale |
2024-09-05 4:54 pm |
Trevi Therapeutics Inc. | TRVI | GOOD JENNIFER L President & CEO |
55,121 | $3.0876 | $170,193 | 323,025 (Direct) |
View |
| 2024-08-27 Sale |
2024-08-29 4:55 pm |
Trevi Therapeutics Inc. | TRVI | Meeker David P Director |
4,555 | $2.9314 | $13,353 | 352,489 (Direct) |
View |
| 2024-08-19 Sale |
2024-08-21 4:00 pm |
Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Scientific Officer |
16,496 | $2.9633 | $48,883 | 220,315 (Direct) |
View |
| 2024-08-14 Sale |
2024-08-16 4:47 pm |
Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Scientific Officer |
31,505 | $2.7687 | $87,228 | 319,868 (Direct) |
View |
| 2024-05-29 Sale |
2024-05-31 4:07 pm |
Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Scientific Officer |
53,368 | $2.5504 | $136,110 | 214,433 (Direct) |
View |
| 2024-05-22 Sale |
2024-05-24 4:12 pm |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
4,350 | $2.6402 | $11,485 | 101,404 (Direct) |
View |
| 2024-05-20 Sale |
2024-05-22 4:30 pm |
Trevi Therapeutics Inc. | TRVI | GOOD JENNIFER L President & CEO |
25,037 | $2.8588 | $71,576 | 246,502 (Direct) |
View |
| 2024-05-10 Sale |
2024-05-14 4:51 pm |
Trevi Therapeutics Inc. | TRVI | GOOD JENNIFER L President & CEO |
4,578 | $2.9 | $13,276 | 271,539 (Direct) |
View |
| 2023-10-11 Sale |
2023-10-12 4:00 pm |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
785 | $2.02 | $1,586 | 100,069 (Direct) |
View |
| 2023-09-11 Sale |
2023-09-13 4:06 pm |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
711 | $2.2 | $1,564 | 100,854 (Direct) |
View |
| 2023-08-11 Sale |
2023-08-14 4:00 pm |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
682 | $2.36 | $1,610 | 101,565 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-25 Exercise |
2025-03-26 4:30 pm |
N/A 2025-05-14 |
Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Scientific Officer |
2,631 | $0 | 221,373 (Direct) |
View |
| 2025-03-25 Exercise |
2025-03-26 4:30 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Scientific Officer |
2,631 | $1.43 | 221,373 (Direct) |
View |
| 2025-03-21 Exercise |
2025-03-25 4:30 pm |
N/A 2025-05-14 |
Trevi Therapeutics Inc. | TRVI | GOOD JENNIFER L President & CEO |
5,263 | $0 | 213,313 (Direct) |
View |
| 2025-03-21 Exercise |
2025-03-25 4:30 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | GOOD JENNIFER L President & CEO |
5,263 | $1.43 | 213,313 (Direct) |
View |
| 2025-03-10 Option Award |
2025-03-12 4:00 pm |
2025-03-10 2034-02-14 |
Trevi Therapeutics Inc. | TRVI | GOOD JENNIFER L President & CEO |
54,400 | $0 | 54,400 (Direct) |
View |
| 2025-03-10 Option Award |
2025-03-12 4:00 pm |
2025-03-10 2034-02-14 |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
38,400 | $0 | 38,400 (Direct) |
View |
| 2025-03-10 Option Award |
2025-03-12 4:00 pm |
2025-03-10 2034-02-14 |
Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Scientific Officer |
32,000 | $0 | 32,000 (Direct) |
View |
| 2025-03-10 Option Award |
2025-03-12 4:00 pm |
2025-03-10 2034-02-14 |
Trevi Therapeutics Inc. | TRVI | Galletta Christopher See Remarks |
4,560 | $0 | 4,560 (Direct) |
View |
| 2025-03-10 Exercise |
2025-03-12 4:00 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Simon Farrell Chief Commercial Officer |
63,813 | $3.91 | 145,237 (Direct) |
View |
| 2025-03-10 Exercise |
2025-03-12 4:00 pm |
N/A 2031-02-16 |
Trevi Therapeutics Inc. | TRVI | Simon Farrell Chief Commercial Officer |
112,563 | $0 | 145,237 (Direct) |
View |
| 2025-03-10 Option Award |
2025-03-12 4:00 pm |
2025-03-10 2034-02-14 |
Trevi Therapeutics Inc. | TRVI | Simon Farrell Chief Commercial Officer |
38,400 | $0 | 145,237 (Direct) |
View |
| 2025-03-10 Exercise |
2025-03-12 4:00 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Simon Farrell Chief Commercial Officer |
31,250 | $0.511 | 145,237 (Direct) |
View |
| 2025-03-10 Exercise |
2025-03-12 4:00 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Simon Farrell Chief Commercial Officer |
17,500 | $3.21 | 145,237 (Direct) |
View |
| 2025-02-18 Option Award |
2025-02-20 4:00 pm |
N/A 2035-02-17 |
Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Scientific Officer |
116,000 | $0 | 116,000 (Direct) |
View |
| 2025-02-18 Option Award |
2025-02-20 4:00 pm |
N/A 2035-02-17 |
Trevi Therapeutics Inc. | TRVI | Cassella James V Chief Development Officer |
257,500 | $0 | 257,500 (Direct) |
View |
| 2025-02-18 Option Award |
2025-02-20 4:00 pm |
N/A 2035-02-17 |
Trevi Therapeutics Inc. | TRVI | Simon Farrell Chief Commercial Officer |
225,500 | $0 | 225,500 (Direct) |
View |
| 2025-02-18 Option Award |
2025-02-20 4:00 pm |
N/A 2035-02-17 |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
225,500 | $0 | 225,500 (Direct) |
View |
| 2025-02-18 Option Award |
2025-02-20 4:00 pm |
N/A 2035-02-17 |
Trevi Therapeutics Inc. | TRVI | GOOD JENNIFER L President & CEO |
811,000 | $0 | 811,000 (Direct) |
View |
| 2025-02-18 Option Award |
2025-02-20 4:00 pm |
N/A 2035-02-17 |
Trevi Therapeutics Inc. | TRVI | Galletta Christopher See Remarks |
41,000 | $0 | 41,000 (Direct) |
View |
| 2025-01-07 Exercise |
2025-01-10 4:14 pm |
N/A 2032-02-10 |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
6,000 | $0 | 153,910 (Direct) |
View |
| 2025-01-07 Exercise |
2025-01-10 4:14 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
6,000 | $0.511 | 153,910 (Direct) |
View |
| 2024-12-13 Exercise |
2024-12-17 4:30 pm |
N/A 2032-02-10 |
Trevi Therapeutics Inc. | TRVI | Galletta Christopher See Remarks |
15,000 | $0 | 39,935 (Direct) |
View |
| 2024-12-13 Exercise |
2024-12-17 4:30 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Galletta Christopher See Remarks |
15,000 | $0.511 | 39,935 (Direct) |
View |
| 2024-09-30 Option Award |
2024-10-01 5:04 pm |
N/A 2034-09-29 |
Trevi Therapeutics Inc. | TRVI | Cassella James V Chief Development Officer |
400,000 | $0 | 400,000 (Direct) |
View |
| 2024-09-06 Exercise |
2024-09-09 5:00 pm |
N/A 2024-11-24 |
Trevi Therapeutics Inc. | TRVI | GOOD JENNIFER L President & CEO |
6,059 | $0 | 215,153 (Direct) |
View |
| 2024-09-06 Exercise |
2024-09-09 5:00 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | GOOD JENNIFER L President & CEO |
6,059 | $1.43 | 215,153 (Direct) |
View |
| 2024-09-03 Exercise |
2024-09-05 4:54 pm |
N/A 2024-11-24 |
Trevi Therapeutics Inc. | TRVI | GOOD JENNIFER L President & CEO |
55,121 | $0 | 323,025 (Direct) |
View |
| 2024-09-03 Exercise |
2024-09-05 4:54 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | GOOD JENNIFER L President & CEO |
55,121 | $1.43 | 323,025 (Direct) |
View |
| 2024-08-27 Exercise |
2024-08-29 4:55 pm |
N/A 2024-11-24 |
Trevi Therapeutics Inc. | TRVI | Meeker David P Director |
4,555 | $0 | 352,489 (Direct) |
View |
| 2024-08-27 Exercise |
2024-08-29 4:55 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Meeker David P Director |
4,555 | $1.43 | 352,489 (Direct) |
View |
| 2024-08-19 Exercise |
2024-08-21 4:00 pm |
N/A 2024-11-24 |
Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Scientific Officer |
16,496 | $0 | 220,315 (Direct) |
View |
| 2024-08-19 Exercise |
2024-08-21 4:00 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Scientific Officer |
16,496 | $1.43 | 220,315 (Direct) |
View |
| 2024-08-14 Exercise |
2024-08-16 4:47 pm |
N/A 2024-11-24 |
Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Scientific Officer |
31,505 | $0 | 319,868 (Direct) |
View |
| 2024-08-14 Exercise |
2024-08-16 4:47 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Scientific Officer |
31,505 | $1.43 | 319,868 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-14 4:40 pm |
N/A 2034-06-12 |
Trevi Therapeutics Inc. | TRVI | Mathers Edward T Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-14 4:30 pm |
N/A 2034-06-12 |
Trevi Therapeutics Inc. | TRVI | Cassella James V Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-14 4:30 pm |
N/A 2034-06-12 |
Trevi Therapeutics Inc. | TRVI | Heffernan Michael Thomas Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-14 4:30 pm |
N/A 2034-06-12 |
Trevi Therapeutics Inc. | TRVI | Meeker David P Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-14 4:30 pm |
N/A 2034-06-12 |
Trevi Therapeutics Inc. | TRVI | VANLENT ANNE Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-14 4:30 pm |
N/A 2034-06-12 |
Trevi Therapeutics Inc. | TRVI | Colangelo Dominick Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2024-05-29 Exercise |
2024-05-31 4:07 pm |
N/A 2024-07-01 |
Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Scientific Officer |
59,354 | $0 | 214,433 (Direct) |
View |
| 2024-05-29 Exercise |
2024-05-31 4:07 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Scientific Officer |
59,354 | $2.19 | 214,433 (Direct) |
View |
| 2024-05-22 Exercise |
2024-05-24 4:12 pm |
N/A 2032-02-10 |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
16,043 | $0 | 101,404 (Direct) |
View |
| 2024-05-22 Exercise |
2024-05-24 4:12 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
16,043 | $0.511 | 101,404 (Direct) |
View |
| 2024-05-20 Exercise |
2024-05-22 4:30 pm |
N/A 2024-07-01 |
Trevi Therapeutics Inc. | TRVI | GOOD JENNIFER L President & CEO |
25,037 | $0 | 246,502 (Direct) |
View |
| 2024-05-20 Exercise |
2024-05-22 4:30 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | GOOD JENNIFER L President & CEO |
25,037 | $2.19 | 246,502 (Direct) |
View |
| 2024-05-10 Exercise |
2024-05-14 4:51 pm |
N/A 2024-07-01 |
Trevi Therapeutics Inc. | TRVI | GOOD JENNIFER L President & CEO |
4,578 | $0 | 271,539 (Direct) |
View |
| 2024-05-10 Exercise |
2024-05-14 4:51 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | GOOD JENNIFER L President & CEO |
4,578 | $2.19 | 271,539 (Direct) |
View |
| 2024-02-15 Option Award |
2024-02-16 4:44 pm |
N/A 2034-02-14 |
Trevi Therapeutics Inc. | TRVI | Galletta Christopher See Remarks |
28,500 | $0 | 28,500 (Direct) |
View |
| 2024-02-15 Option Award |
2024-02-16 4:43 pm |
N/A 2034-02-14 |
Trevi Therapeutics Inc. | TRVI | Simon Farrell Chief Commercial Officer |
175,000 | $0 | 175,000 (Direct) |
View |
| 2024-02-15 Option Award |
2024-02-16 4:43 pm |
N/A 2034-02-14 |
Trevi Therapeutics Inc. | TRVI | Clark David J Chief Medical Officer |
175,000 | $0 | 175,000 (Direct) |
View |
| 2024-02-15 Option Award |
2024-02-16 4:43 pm |
N/A 2034-02-14 |
Trevi Therapeutics Inc. | TRVI | GOOD JENNIFER L President & CEO |
630,000 | $0 | 630,000 (Direct) |
View |
| 2024-02-15 Option Award |
2024-02-16 4:42 pm |
N/A 2034-02-14 |
Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Scientific Officer |
150,000 | $0 | 150,000 (Direct) |
View |
| 2024-02-15 Option Award |
2024-02-16 4:42 pm |
N/A 2034-02-14 |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
175,000 | $0 | 175,000 (Direct) |
View |
| 2023-10-11 Exercise |
2023-10-12 4:00 pm |
N/A 2032-02-10 |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
2,292 | $0 | 100,069 (Direct) |
View |
| 2023-10-11 Exercise |
2023-10-12 4:00 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
2,292 | $0.511 | 100,069 (Direct) |
View |
| 2023-09-11 Exercise |
2023-09-13 4:06 pm |
N/A 2032-02-10 |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
2,291 | $0 | 100,854 (Direct) |
View |
| 2023-09-11 Exercise |
2023-09-13 4:06 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
2,291 | $0.511 | 100,854 (Direct) |
View |
| 2023-08-11 Exercise |
2023-08-14 4:00 pm |
N/A 2032-02-10 |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
2,292 | $0 | 101,565 (Direct) |
View |
| 2023-08-11 Exercise |
2023-08-14 4:00 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
2,292 | $0.511 | 101,565 (Direct) |
View |